TY - JOUR
T1 - Lysine addressability and mammalian cell interactions of bacteriophage λ procapsids
AU - Koudelka, Kristopher J.
AU - Ippoliti, Shannon
AU - Medina, Elizabeth
AU - Shriver, Leah P.
AU - Trauger, Sunia A.
AU - Catalano, Carlos E.
AU - Manchester, Marianne
PY - 2013/12/9
Y1 - 2013/12/9
N2 - Chemically or genetically modified virus particles, termed viral nanoparticles (VNPs), are being explored in applications such as drug delivery, vaccine development, and materials science. Each virus platform has inherent properties and advantages based on its structure, molecular composition, and biomolecular interactions. Bacteriophage λ was studied for its lysine addressability, stability, cellular uptake, and the ability to modify its cellular uptake. λ procapsids could be labeled primarily at a single residue on the gpE capsid protein as determined by tandem mass spectrometry, providing a unique attachment site for further capsid modification. Bioconjugation of transferrin to the procapsids mediated specific interaction with transferrin receptor-expressing cells. These studies demonstrate the utility of bacteriophage λ procapsids and their potential use as targeted drug delivery vehicles.
AB - Chemically or genetically modified virus particles, termed viral nanoparticles (VNPs), are being explored in applications such as drug delivery, vaccine development, and materials science. Each virus platform has inherent properties and advantages based on its structure, molecular composition, and biomolecular interactions. Bacteriophage λ was studied for its lysine addressability, stability, cellular uptake, and the ability to modify its cellular uptake. λ procapsids could be labeled primarily at a single residue on the gpE capsid protein as determined by tandem mass spectrometry, providing a unique attachment site for further capsid modification. Bioconjugation of transferrin to the procapsids mediated specific interaction with transferrin receptor-expressing cells. These studies demonstrate the utility of bacteriophage λ procapsids and their potential use as targeted drug delivery vehicles.
UR - https://www.scopus.com/pages/publications/84890378176
U2 - 10.1021/bm401577f
DO - 10.1021/bm401577f
M3 - Article
C2 - 24251756
AN - SCOPUS:84890378176
SN - 1525-7797
VL - 14
SP - 4169
EP - 4176
JO - Biomacromolecules
JF - Biomacromolecules
IS - 12
ER -